Hemo Organic Ltd submits unaudited Q2 FY2026 results to BSE

What Hemo Organic Ltd announced

On 15 July 2026, Hemo Organic Ltd (BSE: 524590) submitted its unaudited financial results for the quarter ended 30 June 2026, together with a limited review report. The filing was made through the Bombay Stock Exchange’s electronic portal and is recorded under the subject “Submission of Un‑audited financial results along with limited review report for the quarter ended on 30th June, 2026”.

Details of the filing

The submission consists of two parts:

1. Unaudited financial statements – balance sheet, profit & loss account, and cash‑flow statement for the three‑month period ending 30 June 2026. These statements have not been examined by an independent statutory auditor.
2. Limited review report – a review performed by a qualified chartered accountant, providing limited assurance that the financial statements are free from material misstatement, but not a full audit opinion.

The filing does not contain any quantitative disclosures such as revenue, net profit, or earnings per share. The company’s announcement is limited to the fact of filing and the nature of the accompanying review.

Key facts at a glance

Why this matters for investors

The submission signals that Hemo Organic is complying with its quarterly reporting obligations, albeit without a full audit. A limited review provides a lower level of assurance, which may affect the confidence of certain investors who rely on audited figures for valuation. The absence of disclosed financial numbers means that shareholders cannot assess the company’s performance for the quarter until a full audited set of results is released, typically after the statutory audit is completed.

Conclusion

Hemo Organic Ltd has fulfilled its regulatory requirement by filing unaudited results and a limited review report for Q2 FY2026 on 15 July 2026. While the filing confirms compliance, it does not reveal any financial metrics, and the results remain subject to a full audit before definitive conclusions about the quarter’s performance can be drawn.